158 related articles for article (PubMed ID: 6406138)
1. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
3. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
4. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
[TBL] [Abstract][Full Text] [Related]
5. First year clinical experience with six levonorgestrel rods as subdermal contraception.
Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
[TBL] [Abstract][Full Text] [Related]
6. A new delivery system for contraceptive steroids.
Segal S
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
[TBL] [Abstract][Full Text] [Related]
7. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
Holma P; Robertson DN
Contraception; 1985 Aug; 32(2):163-71. PubMed ID: 3935372
[TBL] [Abstract][Full Text] [Related]
9. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of levonorgestrel in women during longterm use of Norplants.
Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
Contraception; 1980 Dec; 22(6):583-96. PubMed ID: 6971208
[TBL] [Abstract][Full Text] [Related]
11. Subdermal contraceptive implants.
Peralta O; Diaz S; Croxatto H
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
[TBL] [Abstract][Full Text] [Related]
12. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
13. Androgen levels in women using Norplant implants.
Olsson SE; Odlind V; Johansson E
Contraception; 1986 Aug; 34(2):157-67. PubMed ID: 2946553
[TBL] [Abstract][Full Text] [Related]
14. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
Thomsen RJ; Pasquale S; Nosher J
Int J Gynaecol Obstet; 1985 Jun; 23(3):223-7. PubMed ID: 2865186
[TBL] [Abstract][Full Text] [Related]
16. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
Robertson DN; Sivin I; Nash HA; Braun J; Dinh J
Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
[TBL] [Abstract][Full Text] [Related]
17. Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
Kurunmäki H; Toivonen J; Lähteenmäki PL; Luukkainen T
Contraception; 1984 Nov; 30(5):431-42. PubMed ID: 6440739
[TBL] [Abstract][Full Text] [Related]
18. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
[TBL] [Abstract][Full Text] [Related]
19. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
20. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Haukkamaa M
Contraception; 1986 Jun; 33(6):559-65. PubMed ID: 3095023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]